ISPIRE TECHNOLOGY INC (ISPR)

US46501C1009 - Common Stock

6.21  -0.04 (-0.64%)

After market: 6.21 0 (0%)

Fundamental Rating

2

Taking everything into account, ISPR scores 2 out of 10 in our fundamental rating. ISPR was compared to 8 industry peers in the Tobacco industry. While ISPR seems to be doing ok healthwise, there are quite some concerns on its profitability. ISPR has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

ISPR had negative earnings in the past year.
ISPR had a negative operating cash flow in the past year.

1.2 Ratios

ISPR has a Return On Assets of -14.72%. This is in the lower half of the industry: ISPR underperforms 75.00% of its industry peers.
ISPR has a Return On Equity of -61.82%. This is comparable to the rest of the industry: ISPR outperforms 50.00% of its industry peers.
Industry RankSector Rank
ROA -14.72%
ROE -61.82%
ROIC N/A
ROA(3y)-6.85%
ROA(5y)N/A
ROE(3y)-25.95%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 20.71%, ISPR is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of ISPR has grown nicely.
ISPR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.08%
GM growth 5YN/A

6

2. Health

2.1 Basic Checks

ISPR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ISPR has been increased compared to 1 year ago.
ISPR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

ISPR has an Altman-Z score of 2.79. This is not the best score and indicates that ISPR is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of ISPR (2.79) is comparable to the rest of the industry.
There is no outstanding debt for ISPR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.79
ROIC/WACCN/A
WACC9.07%

2.3 Liquidity

A Current Ratio of 1.13 indicates that ISPR should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.13, ISPR is doing good in the industry, outperforming 62.50% of the companies in the same industry.
A Quick Ratio of 1.05 indicates that ISPR should not have too much problems paying its short term obligations.
ISPR has a Quick ratio of 1.05. This is in the better half of the industry: ISPR outperforms 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 1.05

2

3. Growth

3.1 Past

ISPR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -172.56%.
Looking at the last year, ISPR shows a decrease in Revenue. The Revenue has decreased by -6.37% in the last year.
Measured over the past years, ISPR shows a very strong growth in Revenue. The Revenue has been growing by 33.80% on average per year.
EPS 1Y (TTM)-172.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-233.33%
Revenue 1Y (TTM)-6.37%
Revenue growth 3Y33.8%
Revenue growth 5YN/A
Sales Q2Q%-8.23%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y67.8%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year61.99%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ISPR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ISPR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ISPR!.
Industry RankSector Rank
Dividend Yield N/A

ISPIRE TECHNOLOGY INC

NASDAQ:ISPR (11/22/2024, 8:00:02 PM)

After market: 6.21 0 (0%)

6.21

-0.04 (-0.64%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryTobacco
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap351.80M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.72%
ROE -61.82%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 20.71%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.15
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.13
Quick Ratio 1.05
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-172.56%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y67.8%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-6.37%
Revenue growth 3Y33.8%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y